These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1086 related articles for article (PubMed ID: 27643552)
1. Tanshinone IIA protects against myocardial ischemia reperfusion injury by activating the PI3K/Akt/mTOR signaling pathway. Li Q; Shen L; Wang Z; Jiang HP; Liu LX Biomed Pharmacother; 2016 Dec; 84():106-114. PubMed ID: 27643552 [TBL] [Abstract][Full Text] [Related]
2. [Protective effect against myocardial ischemia reperfusion injuries induced by hyperoside preconditioning and its relationship with PI3K/Akt signaling pathway in rats]. Han J; Xuan JL; Hu HR; Chen ZW Zhongguo Zhong Yao Za Zhi; 2015 Jan; 40(1):118-23. PubMed ID: 25993800 [TBL] [Abstract][Full Text] [Related]
3. Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway. Zhang J; Jiang H; Liu DH; Wang GN Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6736-6743. PubMed ID: 31378917 [TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA Affects Autophagy and Apoptosis of Glioma Cells by Inhibiting Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Pathway. Ding L; Ding L; Wang S; Wang S; Wang W; Wang W; Lv P; Lv P; Zhao D; Zhao D; Chen F; Chen F; Meng T; Meng T; Dong L; Dong L; Qi L; Qi L Pharmacology; 2017; 99(3-4):188-195. PubMed ID: 27889779 [TBL] [Abstract][Full Text] [Related]
5. Research on protective mechanism of ibuprofen in myocardial ischemia-reperfusion injury in rats through the PI3K/Akt/mTOR signaling pathway. Chi Y; Ma Q; Ding XQ; Qin X; Wang C; Zhang J Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4465-4473. PubMed ID: 31173323 [TBL] [Abstract][Full Text] [Related]
6. [Effects of PI3K/Akt-eNOS signaling pathway on total flavones in Clematis filamentosa post-conditioning alleviated of myocardial ischemia-reperfusion injury in rats]. Nie Y; Ding L; Huang HC; Xu LK; Zhao J; Yang YJ Zhongguo Zhong Yao Za Zhi; 2018 Dec; 43(23):4692-4697. PubMed ID: 30717560 [TBL] [Abstract][Full Text] [Related]
7. Cardioprotective effects of total flavonoids from Jinhe Yangxin prescription by activating the PI3K/Akt signaling pathway in myocardial ischemia injury. Cheng Y; Tan J; Li H; Kong X; Liu Y; Guo R; Li G; Yang B; Pei M Biomed Pharmacother; 2018 Feb; 98():308-317. PubMed ID: 29274587 [TBL] [Abstract][Full Text] [Related]
8. [Effect of adiponectin postconditioning against myocardial ischemia/reperfusion injury in rats and role of ADP/PI3K/Akt pathway in adiponectin postconditioning]. Zhao LJ; Cui LS; Zhang JY; Wang YL Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Apr; 33(4):308-313. PubMed ID: 29926635 [TBL] [Abstract][Full Text] [Related]
9. Syringic acid mitigates myocardial ischemia reperfusion injury by activating the PI3K/Akt/GSK-3β signaling pathway. Liu G; Zhang BF; Hu Q; Liu XP; Chen J Biochem Biophys Res Commun; 2020 Oct; 531(2):242-249. PubMed ID: 32798018 [TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA decreases the protein expression of EGFR, and IGFR blocking the PI3K/Akt/mTOR pathway in gastric carcinoma AGS cells both in vitro and in vivo. Su CC; Chiu TL Oncol Rep; 2016 Aug; 36(2):1173-9. PubMed ID: 27277844 [TBL] [Abstract][Full Text] [Related]
11. Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury. Cheng XY; Gu XY; Gao Q; Zong QF; Li XH; Zhang Y Mol Med Rep; 2016 Jul; 14(1):797-803. PubMed ID: 27221008 [TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin gallate exerts protective effects against myocardial ischemia/reperfusion injury through the PI3K/Akt pathway-mediated inhibition of apoptosis and the restoration of the autophagic flux. Xuan F; Jian J Int J Mol Med; 2016 Jul; 38(1):328-36. PubMed ID: 27246989 [TBL] [Abstract][Full Text] [Related]
13. Glutamine protects myocardial ischemia-reperfusion injury in rats through the PI3K/Akt signaling pathway. Cui ZH; Zhang XJ; Shang HQ; Wang X; Rong D Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):444-451. PubMed ID: 31957859 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of autophagy via activation of PI3K/Akt/mTOR pathway contributes to the protection of hesperidin against myocardial ischemia/reperfusion injury. Li X; Hu X; Wang J; Xu W; Yi C; Ma R; Jiang H Int J Mol Med; 2018 Oct; 42(4):1917-1924. PubMed ID: 30066841 [TBL] [Abstract][Full Text] [Related]
15. Hydrogen‑rich solution against myocardial injury and aquaporin expression via the PI3K/Akt signaling pathway during cardiopulmonary bypass in rats. Song D; Liu X; Diao Y; Sun Y; Gao G; Zhang T; Chen K; Pei L Mol Med Rep; 2018 Aug; 18(2):1925-1938. PubMed ID: 29956781 [TBL] [Abstract][Full Text] [Related]
16. Cardio-protective effect of tetrahydrocurcumin, the primary hydrogenated metabolite of curcumin in vivo and in vitro: Induction of apoptosis and autophagy via PI3K/AKT/mTOR pathways. Chen X; Xie Q; Zhu Y; Xu J; Lin G; Liu S; Su Z; Lai X; Li Q; Xie J; Yang X Eur J Pharmacol; 2021 Nov; 911():174495. PubMed ID: 34555398 [TBL] [Abstract][Full Text] [Related]
17. Cardioprotection of tilianin ameliorates myocardial ischemia-reperfusion injury: Role of the apoptotic signaling pathway. Zeng C; Jiang W; Zheng R; He C; Li J; Xing J PLoS One; 2018; 13(3):e0193845. PubMed ID: 29538428 [TBL] [Abstract][Full Text] [Related]
18. Salidroside suppressing LPS-induced myocardial injury by inhibiting ROS-mediated PI3K/Akt/mTOR pathway in vitro and in vivo. Chen L; Liu P; Feng X; Ma C J Cell Mol Med; 2017 Dec; 21(12):3178-3189. PubMed ID: 28905500 [TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway. Won SH; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Jung DB; Shin JM; Kwon TR; Yun SM; Lee MH; Choi SH; Lü J; Kim SH Biol Pharm Bull; 2010; 33(11):1828-34. PubMed ID: 21048307 [TBL] [Abstract][Full Text] [Related]
20. Cardioprotection of hydralazine against myocardial ischemia/reperfusion injury in rats. Li C; Su Z; Ge L; Chen Y; Chen X; Li Y Eur J Pharmacol; 2020 Feb; 869():172850. PubMed ID: 31830459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]